Marimed (MRMD) Other Non Operating Income (2014 - 2026)

Marimed (MRMD) posted quarterly Other Non Operating Income of $699000.0 for Q1 2026, up 192.83% quarter-over-quarter from -$753000.0 in Q4 2025.

Marimed (MRMD) Other Non Operating Income (2014 - 2026) Analysis & Trends

Marimed (MRMD) has reported Other Non Operating Income for 11 consecutive years, with $699000.0 the latest figure, recorded in Q1 2026.

In Q1 2026, Other Non Operating Income changed N/A year-over-year to $699000.0; the TTM figure through Mar 2026 stood at -$18000.0 (up 40.0% YoY), while the FY2025 annual figure was -$717000.0, down 1334.0% from the prior year.
Other Non Operating Income climbed to $699000.0 in Q1 2026 per MRMD's latest filing, from -$753000.0 in the prior quarter.
Across five years, Other Non Operating Income topped out at $1.0 million in Q1 2022 and bottomed at -$8.9 million in Q4 2023.
Historically, Other Non Operating Income has averaged -$749928.6 across 5 years, with a median of -$27000.0 in 2022.
Annual changes were most pronounced in 2022 — Other Non Operating Income jumped 100300.0% — and 2023, when it plunged 36879.17%.
Marimed's Other Non Operating Income stood at -$24000.0 in 2022, then slumped by 36879.17% to -$8.9 million in 2023, then soared by 99.66% to -$30000.0 in 2024, then slumped by 2410.0% to -$753000.0 in 2025, then surged by 192.83% to $699000.0 in 2026.
Business Quant data shows MRMD's Other Non Operating Income at $699000.0 in Q1 2026, -$753000.0 in Q4 2025, and $19000.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.98 Bn	43.02 Bn	-
2	Teva Pharmaceutical Industries	43.28 Bn	39.62 Bn	2.15 Bn
3	Zoetis	31.78 Bn	30.11 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.71 Bn	22.91 Bn	5.10 Bn
5	United Therapeutics	22.25 Bn	19.59 Bn	683.80 Mn
6	Viatris	18.72 Bn	17.83 Bn	1.46 Bn
7	Neurocrine Biosciences	15.57 Bn	15.18 Bn	935.80 Mn
8	Elanco Animal Health	11.87 Bn	11.34 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.14 Bn	9.97 Bn	-
10	Marimed	28.08 Mn	17.74 Mn	16.23 Mn

Download Data